United Kingdom· GB-APID-39970511000001103
Ryaltris 25micrograms/dose / 600micrograms/dose nasal spray
A medicinal product containing mometasone + olopatadine, registered in United Kingdom by Glenmark Pharmaceuticals Europe Ltd.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Mometasone + Olopatadine
- Manufacturer
- Glenmark Pharmaceuticals Europe Ltd
- Country
- United Kingdom (GB)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin5060204166822
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Mometasone + olopatadine in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- PolandRyaltrisGlenmark Pharmaceuticals s.r.o.
- NetherlandsRyaltris 25/600 microgram/dosis neusspray, suspensieMedcor Pharmaceuticals B.V.
- CzechiaRYALTRISGlenmark Pharmaceuticals s.r.o., Praha
- SwitzerlandRyaltris 25 μg / 600 μg, Nasenspray, SuspensionNOBEL Pharma Schweiz AG
- SwedenMometasone furoate/Olopatadine Glenmark 25 mikrogram/dos + 600 mikrogram/dos Nässpray, suspensionGlenmark Arzneimittel GmbH
- United StatesRyaltrisGlenmark Pharmaceuticals Inc., USA
- IrelandRyaltris 25 microgram/actuation + 600 microgram/actuation nasal spray, suspensionPCO Manufacturing Ltd.
- GermanyRyaltrisGlenmark Pharmaceuticals S.R.O.
Authorised across Europe · EMA
The same active substance is authorised in 20 EEA countries. Names it is sold under:
- Austria · Ryaltris
- Belgium · Ryaltris
- Czechia · Ryaltris
- Germany · Ryaltris
- Denmark · Ryaltris
- Spain · Ryaltris
- Finland · Ryaltris
- France · Ryaltris
- Ireland · Ryaltris
- Italy · Rineffix, Ryaltris
- Lithuania · Ryaltris
- Luxembourg · Ryaltris
- Latvia · Ryaltris
- Malta · Ryaltris
- Netherlands · Ryaltris
- Norway · Ryaltris
- Poland · Ryaltris
- Romania · Ryaltris
- Sweden · Mometasone Furoate/Olopatadine Glenmark, Ryaltris
- Slovakia · Ryaltris
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/719d5d47-c127-4a5d-b366-573437a30490 GET /v1/drugs/719d5d47-c127-4a5d-b366-573437a30490?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "39970511000001103",
"desc": "Ryaltris 25micrograms/dose / 600micrograms/dose nasal spray (Glenmark Pharmaceuticals Europe Ltd)",
"form": "Spray",
"vpid": "40015611000001105",
"source": "dmd",
"vtm_id": "39997211000001106",
"strength": "600 microgram",
"substance": "Mometasone + Olopatadine",
"ingredient": "Olopatadine hydrochloride",
"supplier_code": "15537011000001107"
}See everything about mometasone + olopatadine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.